Major Depressive Disorder
10 competing products in clinical development for Major Depressive Disorder.
Pipeline by Phase
Pre-clinical1
Phase 13
Phase 24
Phase 32
All Products (10)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Pramipexole ER + Escitalopram | Cipla | Phase 2 | Recruiting | 42 |
| Duloxetine | Eli Lilly | Phase 3 | Completed | 40 |
| Duloxetine + Paroxetine | Eli Lilly | Phase 3 | Completed | 40 |
| LY2216684 + Placebo + Escitalopram | Eli Lilly | Phase 2 | Completed | 35 |
| quetiapine extended release (XR) + Placebo | Astellas Pharma | Phase 2 | Completed | 35 |
| ONO-2333Ms Experimental 2 + Placebo + ONO-2333Ms Experimental 1 | Ono Pharmaceutical | Phase 2 | Completed | 35 |
| LY2216684 + Digoxin | Eli Lilly | Phase 1 | Completed | 29 |
| FK949E | Astellas Pharma | Phase 1 | Completed | 29 |
| FK949E | Astellas Pharma | Phase 1 | Completed | 29 |
| Duloxetine Hydrochloride | Eli Lilly | Pre-clinical | Completed | 26 |